When there is only the presence of Aβ42 (A+) without evidence of tau pathology (T-), the term used is “Alzheimer’s pathologic change,” representing the initial stage of the AD pathological spectrum according to the amyloid cascade hypothesis. The gene discussed is MAPT; the disease is Alzheimer disease.